ProlyteORS, the flagship brand of Cipla Health Limited, welcomes the recent directive from the Food Safety and Standards Authority of India (FSSAI), which mandates the removal of the term 'ORS' from food and beverage product names,

Stay up-to-date with the Cipla Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a prominent stock. Explore the latest information on Cipla, including: Last traded price 1582.

Cipla enters obesity and diabetes drug market with Eli Lilly's tirzepatide 'Yurpeak'; Nuvama retains 'Hold' on Cipla stock, raises target price to ₹1,725 citing strategic entry into high-growth GLP-1 therapy segment.

Cipla shares drop 3.7% after Eli Lilly deal, but analysts see strong growth in India's obesity market—learn more about the opportunity!

Stocks to watch today include Cipla, IndusInd, Wonderland Foods, Hero MotoCorp, Premier Energies, Welspun, Coal India, and NTPC Green Energy.

Cipla, Hindustan Unilever Ltd., Colgate, Laurus Labs, Bharat Forge, and the Auto and Airlines sectors are drawing brokerage commentary today.

Cipla's share price shows a promising return of 4.83% over the past week. The pharmaceutical giant's stock closed at Rs 1,663.60 yesterday, reflecting strong market performance.

A decisive breakout above ₹1,580 could trigger further upward momentum, paving the way towards the ₹1,770-₹1,850 target range in the medium term, said Choice Broking.